Alejandro Luna

2.3k total citations
15 papers, 82 citations indexed

About

Alejandro Luna is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Alejandro Luna has authored 15 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Hematology and 4 papers in Immunology. Recurrent topics in Alejandro Luna's work include CAR-T cell therapy research (10 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Alejandro Luna is often cited by papers focused on CAR-T cell therapy research (10 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Alejandro Luna collaborates with scholars based in Spain, United States and Italy. Alejandro Luna's co-authors include Lorenzo Falchi, Vicente Planelles, José Alcamı́, Valentín García‐Gutiérrez, Guiomar Bautista, Juan Luis Steegmann, Mayte Coiras, Fernando de Ory, María Rosa López‐Huertas and Elena Mateos and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Biochemical Pharmacology.

In The Last Decade

Alejandro Luna

12 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandro Luna Spain	7	36	21	16	15	15	15	82
Moraima Jiménez Spain	4	41 1.1×	28 1.3×	23 1.4×	16 1.1×	12 0.8×	10	93
Chung Mun Alice Lin United Kingdom	4	34 0.9×	15 0.7×	10 0.6×	8 0.5×	35 2.3×	9	129
Aurélie Cabannes‐Hamy France	6	54 1.5×	47 2.2×	18 1.1×	8 0.5×	19 1.3×	21	109
Jehane Fadlallah France	5	58 1.6×	18 0.9×	15 0.9×	18 1.2×	33 2.2×	11	111
Norihiro Murakami Japan	6	16 0.4×	43 2.0×	15 0.9×	11 0.7×	19 1.3×	12	100
Tigran Torosian Poland	7	35 1.0×	56 2.7×	13 0.8×	4 0.3×	13 0.9×	18	103
Giovanna Leone Italy	6	25 0.7×	43 2.0×	19 1.2×	6 0.4×	41 2.7×	14	106
Lindsay Rein United States	7	26 0.7×	39 1.9×	16 1.0×	13 0.9×	21 1.4×	22	103
Vesa Lindström Finland	8	23 0.6×	30 1.4×	26 1.6×	27 1.8×	41 2.7×	13	117
Ibrahim Ghemlas Saudi Arabia	6	27 0.8×	57 2.7×	17 1.1×	7 0.5×	15 1.0×	29	109

Countries citing papers authored by Alejandro Luna

Since Specialization

Citations

This map shows the geographic impact of Alejandro Luna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Luna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Luna more than expected).

Fields of papers citing papers by Alejandro Luna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Luna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Luna. The network helps show where Alejandro Luna may publish in the future.

Co-authorship network of co-authors of Alejandro Luna

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Luna. A scholar is included among the top collaborators of Alejandro Luna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Luna. Alejandro Luna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Luna, Alejandro, et al.. (2026). Apheresis CD8+CCR7+CD45RA− T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome. International Journal of Molecular Sciences. 27(2). 866–866.

Luna, Alejandro, et al.. (2024). Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma. OncoImmunology. 13(1). 2321648–2321648. 12 indexed citations

Gómez‐Centurión, Ignacio, Anabelle Chinea, Alexandra Pedraza, et al.. (2024). Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH). Transplantation and Cellular Therapy. 30(9). 914.e1–914.e8.

Melica, Giovanna, Alejandro Luna, Gunjan L. Shah, et al.. (2024). Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort. Transplantation and Cellular Therapy. 31(1). 36–44. 4 indexed citations

Valtis, Yannis K., Roni Shouval, Kai Rejeski, et al.. (2024). Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes. Blood Advances. 9(1). 151–161. 6 indexed citations

Riedell, Peter A., Loretta J. Nastoupil, Alejandro Luna, et al.. (2024). Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis. Blood Advances. 9(5). 1232–1241. 6 indexed citations

Melica, Giovanna, Alejandro Luna, Magdalena Corona, et al.. (2023). From Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T- Cell Therapy: Less Is Better. Blood. 142(Supplement 1). 3514–3514.

Luan, Danny, Roni Shouval, Teng Fei, et al.. (2023). Higher CD4+ T Cell Counts after CAR-T in Large B-Cell Lymphomas Are Significantly Associated with Better Overall Survival. Blood. 142(Supplement 1). 4812–4812. 1 indexed citations

Riedell, Peter A., Loretta J. Nastoupil, Alejandro Luna, et al.. (2023). Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium. Blood. 142(Supplement 1). 617–617. 7 indexed citations

10.

Luttwak, Efrat, Sean M. Devlin, Alejandro Luna, et al.. (2023). Evaluation of the Impact of Tocilizumab Use in Recipients of CAR T Cells for Non-Hodgkin Lymphoma. Blood. 142(Supplement 1). 6898–6898. 1 indexed citations

11.

López‐Jiménez, Javier, Alejandro Luna, Rafael F. Duarte, et al.. (2022). Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation. Transplantation and Cellular Therapy. 28(10). 703.e1–703.e8. 1 indexed citations

12.

Luna, Alejandro, Miguel Á. Galán, Sara Rodríguez-Mora, et al.. (2020). Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission. Journal of Clinical Medicine. 10(1). 42–42. 17 indexed citations

13.

Luna, Alejandro, et al.. (2020). Transfusion support in COVID‐19 patients: Impact on hospital blood component supply during the outbreak. Transfusion. 61(2). 361–367. 14 indexed citations

14.

Rodríguez-Mora, Sara, Alejandro Luna, Virginia Martin, et al.. (2020). Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection. Biochemical Pharmacology. 182. 114203–114203. 11 indexed citations

15.

García‐Gutiérrez, Valentín, Alejandro Luna, Miguel Piris‐Villaespesa, et al.. (2019). Identification of Immunological Parameters Related to Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission. Blood. 134(Supplement_1). 191–191. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact